Bristol-Myers Squibb BMY Total Current Liabilities
Total Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by Bristol-Myers Squibb in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesCurrent.
The official record: Bristol-Myers Squibb’s 10-Q, filed July 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Bristol-Myers Squibb's total current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Bristol-Myers Squibb's total current liabilities?
- Bristol-Myers Squibb (BMY) reported total current liabilities of $18.66B in Q2 2026.
- How has Bristol-Myers Squibb's total current liabilities changed year-over-year?
- Bristol-Myers Squibb's total current liabilities decreased by 32.2% year-over-year, from $27.53B to $18.66B.
- What is the long-term trend for Bristol-Myers Squibb's total current liabilities?
- Over 5 years (2020 to 2025), Bristol-Myers Squibb's total current liabilities has grown at a 4.2% compound annual growth rate (CAGR), from $19.08B to $23.42B.
- What does total current liabilities mean?
- The sum of all obligations due within one year — payables, accrued expenses, current debt, deferred revenue, and other short-term liabilities.